Bruno Vieira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruno Vieira has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Clara Leal
General Surgery Department, Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), Clinical Academic Centre Trás-os-Montes e Alto Douro (CACTMAD), Vila Real, Portugal
4 shared publications - Daniela Martins
General Surgery Department, Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), Clinical Academic Centre Trás-os-Montes e Alto Douro (CACTMAD), Vila Real, Portugal
4 shared publications - Gonçalo Guidi
Unidade Local de Saúde de Trás os Montes e Alto Douro - Hospital de Vila Real, Vila Real, Portugal
4 shared publications - João Pinto-De-Sousa
Department of General Surgery, Centro Hospitalar De Trás-Os-Montes E Alto Douro, Vila Real, Portugal
4 shared publications - Urânia Fernandes
General Surgery Department, Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), Clinical Academic Centre Trás-os-Montes e Alto Douro (CACTMAD), Vila Real, Portugal
4 shared publications Carlos Santos
Attending Surgeon; General Surgery Department, Hospital Centre Hospitalar de Trás-os- Montes e Alto Douro (CHTAMAD), Clinical Academic Centre Trás-os-Montes e Alto Douro (CACTMAD); Vila Real, Portugal
3 shared publications
Latest Publications
- Open Access
- 1 May 2023
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 8 (3) , e213
Breast cancer in young women: a rising threat: A 5-year follow-up comparative study
Introduction: Breast cancer in young women is usually considered as breast cancer occurring in women younger than 40 years and is the most frequent cancer-related cause of death in these patients. In the past few years, there seems to be an increasing trend in the prevalence of breast cancer in young women, which, associated with poorer prognosis, more aggressive histologic features, and more frequent recurrence rates, makes it a rising threat to young women. This study aimed to evaluate the biological behavior of breast cancer in young women in our institution. Material and methods: A retrospective, unicentric, cohort study was conducted between 2012 and 2016. All consecutive patients with breast cancer were enrolled in the study. Cases were divided into two groups: case group, those younger than 40 years, and control group, those 40 years or older. The exclusion criterion was nonoperative treatment. Several clinical and pathologic parameters were evaluated, as well as were overall survival time and disease-free survival time. Results: The incidence of breast cancer in young women presented a rising tendency over the study period. Significant differences were observed in the comparison of the groups according to body mass index, age at menarche, age at birth of the first child, and proliferation rate. There were no differences in overall survival and disease-free survival rates between the groups. Conclusions: Young women had a more symptomatic presentation, a greater tumor proliferation rate, but similar outcomes compared with older patients. Greater multicentric studies are needed to confirm or refute these results.
- 1 May 2023
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 8 (3) , e213
Open AccessBreast cancer in young women: a rising threat: A 5-year follow-up comparative study
Introduction: Breast cancer in young women is usually considered as breast cancer occurring in women younger than 40 years and is the most frequent cancer-related cause of death in these patients. In the past few years, there seems to be an increasing trend in the prevalence of breast cancer in young women, which, associated with poorer prognosis, more aggressive histologic features, and more frequent recurrence rates, makes it a rising threat to young women. This study aimed to evaluate the biological behavior of breast cancer in young women in our institution. Material and methods: A retrospective, unicentric, cohort study was conducted between 2012 and 2016. All consecutive patients with breast cancer were enrolled in the study. Cases were divided into two groups: case group, those younger than 40 years, and control group, those 40 years or older. The exclusion criterion was nonoperative treatment. Several clinical and pathologic parameters were evaluated, as well as were overall survival time and disease-free survival time. Results: The incidence of breast cancer in young women presented a rising tendency over the study period. Significant differences were observed in the comparison of the groups according to body mass index, age at menarche, age at birth of the first child, and proliferation rate. There were no differences in overall survival and disease-free survival rates between the groups. Conclusions: Young women had a more symptomatic presentation, a greater tumor proliferation rate, but similar outcomes compared with older patients. Greater multicentric studies are needed to confirm or refute these results.
- Open Access
- 12 January 2023
- Published by Scholar Publishing in British Journal of Healthcare and Medical Research
- Vol. 10 (1) , 217-224
Micropapillary Thyroid Carcinoma: Not So Harmless as it Seems. A 5-Year Follow-Up Cohort Retrospective Study
Introduction: Differentiated thyroid cancer is becoming increasingly prevalent mostly due to the increasing incidence of micropapillary carcinoma. For low-risk tumors, hemithyroidectomy does not reduce survival and may be associated with higher local recurrence. This study aimed to compare Micropapillary versus Papillary thyroid carcinomas regarding overall survival and disease-free survival. Methods: A retrospective, unicentric, cohort study was carried between 2012 and 2016. Consecutive cases with (micro)papillary thyroid carcinoma were enrolled and divided in microcarcinoma group and control group. Exclusion criteria were loss to follow-up, previous thyroid surgery and non-operative treatment. A comparison of several clinical and pathological parameters, recurrence rate and cumulative survival was performed between groups. Results: Patients with micropapillary carcinomas were younger and frequently asymptomatic. 6.5% of these carcinomas presented a benign cytology (Bethesda II) in this study. 18.9% of these patients were submitted to hemithyroidectomy but 71.4% were thereafter totalized. Micropapillary carcinomas presented higher rate of multifocality but similar lymph node invasion rate, lymph node dissection rate and adjuvant iodine therapy. Patients with micropapillary carcinomas presented less advanced staging but similar recurrence rate and time to recurrence; moreover, higher stage was only related with (older) age of presentation. Conclusions: In this study micropapillary carcinomas presented better staging but similar recurrence rate comparing with papillary carcinomas. Moreover, most of these patients were submitted to totalization. These results question if hemithyroidectomy is still a good option for micropapillary carcinomas and if this staging system is adequate. Larger studies with longer follow-up are needed to confirm or refute these results.
- 12 January 2023
- Published by Scholar Publishing in British Journal of Healthcare and Medical Research
- Vol. 10 (1) , 217-224
Open AccessMicropapillary Thyroid Carcinoma: Not So Harmless as it Seems. A 5-Year Follow-Up Cohort Retrospective Study
Introduction: Differentiated thyroid cancer is becoming increasingly prevalent mostly due to the increasing incidence of micropapillary carcinoma. For low-risk tumors, hemithyroidectomy does not reduce survival and may be associated with higher local recurrence. This study aimed to compare Micropapillary versus Papillary thyroid carcinomas regarding overall survival and disease-free survival. Methods: A retrospective, unicentric, cohort study was carried between 2012 and 2016. Consecutive cases with (micro)papillary thyroid carcinoma were enrolled and divided in microcarcinoma group and control group. Exclusion criteria were loss to follow-up, previous thyroid surgery and non-operative treatment. A comparison of several clinical and pathological parameters, recurrence rate and cumulative survival was performed between groups. Results: Patients with micropapillary carcinomas were younger and frequently asymptomatic. 6.5% of these carcinomas presented a benign cytology (Bethesda II) in this study. 18.9% of these patients were submitted to hemithyroidectomy but 71.4% were thereafter totalized. Micropapillary carcinomas presented higher rate of multifocality but similar lymph node invasion rate, lymph node dissection rate and adjuvant iodine therapy. Patients with micropapillary carcinomas presented less advanced staging but similar recurrence rate and time to recurrence; moreover, higher stage was only related with (older) age of presentation. Conclusions: In this study micropapillary carcinomas presented better staging but similar recurrence rate comparing with papillary carcinomas. Moreover, most of these patients were submitted to totalization. These results question if hemithyroidectomy is still a good option for micropapillary carcinomas and if this staging system is adequate. Larger studies with longer follow-up are needed to confirm or refute these results.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e122
Thyroid Cancer: A Single Portuguese Center Experience
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e122
Thyroid Cancer: A Single Portuguese Center Experience
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e118-e119
Differentiated Thyroid Carcinoma: Proposal of a Follow-up Scheme After Total Thyroidectomy
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e118-e119
Differentiated Thyroid Carcinoma: Proposal of a Follow-up Scheme After Total Thyroidectomy